Paper42663289
Advances in sirtuin research in lung diseases (Review).
Xi S and 4 others. Int J Mol Med, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Advances in sirtuin research in lung diseases (Review). Papers, record 42663289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42663289
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sirtuins | Major topic |
| Lung Diseases | Major topic |
| Humans | |
| Animals | |
| Oxidative Stress |
Source PubMed
References110
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34200413 | Lung Transplantation, Pulmonary Endothelial Inflammation, and Ex-Situ Lung Perfusion: A Review. | Cells | 2021 | https://conductscience.org/library/papers/34200413 | PubMed |
| 2 | 16079181 | Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. | Mol Biol Cell | 2005 | https://conductscience.org/library/papers/16079181 | PubMed |
| 3 | 37965345 | The role of cGAS-STING signaling in pulmonary fibrosis and its therapeutic potential. | Front Immunol | 2023 | https://conductscience.org/library/papers/37965345 | PubMed |
| 4 | 35644425 | Quercetin attenuates sepsis-induced acute lung injury via suppressing oxidative stress-mediated ER stress through activation of SIRT1/AMPK pathways. | Cell Signal | 2022 | https://conductscience.org/library/papers/35644425 | PubMed |
| 5 | 37265380 | Melatonin attenuates lung ischemia-reperfusion injury through SIRT3 signaling-dependent mitophagy in type 2 diabetic rats. | Exp Lung Res | 2023 | https://conductscience.org/library/papers/37265380 | PubMed |
| 6 | 11483616 | Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11483616 | PubMed |
| 7 | 38977688 | Copy number variation introduced by a massive mobile element facilitates global thermal adaptation in a fungal wheat pathogen. | Nat Commun | 2024 | https://conductscience.org/library/papers/38977688 | PubMed |
| 8 | 18823944 | Inhibition of transcriptional activity of c-JUN by SIRT1. | Biochem Biophys Res Commun | 2008 | https://conductscience.org/library/papers/18823944 | PubMed |
| 9 | 35460396 | Propofol Reduces Renal Ischemia Reperfusion-mediated Necroptosis by Up-regulation of SIRT1 in Rats. | Inflammation | 2022 | https://conductscience.org/library/papers/35460396 | PubMed |
| 10 | 34214200 | Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3/PDH axis. | J Pineal Res | 2021 | https://conductscience.org/library/papers/34214200 | PubMed |
| 11 | 17197703 | Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17197703 | PubMed |
| 12 | 34887866 | SIRT1: A Potential Therapeutic Target in Autoimmune Diseases. | Front Immunol | 2021 | https://conductscience.org/library/papers/34887866 | PubMed |
| 13 | 24691964 | Erasers of histone acetylation: the histone deacetylase enzymes. | Cold Spring Harb Perspect Biol | 2014 | https://conductscience.org/library/papers/24691964 | PubMed |
| 14 | 12456660 | Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. | EMBO J | 2002 | https://conductscience.org/library/papers/12456660 | PubMed |
| 15 | 31417401 | Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition. | Front Pharmacol | 2019 | https://conductscience.org/library/papers/31417401 | PubMed |
| 16 | 18835033 | Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18835033 | PubMed |
| 17 | 34405009 | Sirt3 Promoted DNA Damage Repair and Radioresistance Through ATM-Chk2 in Non-small Cell Lung Cancer Cells. | J Cancer | 2021 | https://conductscience.org/library/papers/34405009 | PubMed |
| 18 | 31153040 | Redox control of yeast Sir2 activity is involved in acetic acid resistance and longevity. | Redox Biol | 2019 | https://conductscience.org/library/papers/31153040 | PubMed |
| 19 | 34202229 | SIRT3 Overexpression Ameliorates Asbestos-Induced Pulmonary Fibrosis, mt-DNA Damage, and Lung Fibrogenic Monocyte Recruitment. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34202229 | PubMed |
| 20 | 23843607 | PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells. | J Cell Sci | 2013 | https://conductscience.org/library/papers/23843607 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42663289
GET https://conductscience.org/api/papers/v1/42663289/references?page=2